Provided by Tiger Trade Technology Pte. Ltd.

Compass Therapeutics, Inc.

0.9402
-0.0998-9.60%
Volume:3.95M
Turnover:3.82M
Market Cap:169.32M
PE:-2.33
High:1.05
Open:1.03
Low:0.9401
Close:1.04
52wk High:6.88
52wk Low:0.9401
Shares:180.09M
Float Shares:132.00M
Volume Ratio:2.52
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4039
EPS(LYR):-0.4216
ROE:-56.66%
ROA:-33.03%
PB:1.02
PE(LYR):-2.23

Loading ...

Apr 26, 2022

Major Issues Report

8-K - Current report
Mar 18, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2022

Major Issues Report

8-K - Current report
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Major Issues Report

8-K - Current report
Oct 08, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jul 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 04, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Major Issues Report

8-K - Current report